Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.
Reuters NewMedia, Inc. - Monday September 1 7:31 AM EDT
In a statement the company said scientists led by Montagnier, who helped to discover the AIDS virus in 1983, would use its sheep monoclonal antibodies as part of the quest for a therapy based on kick-starting the body's immune system.
Shares in the company rose three pence to 116-1/2 in midday trading.
KS Biomedix said the identification last year of a second receptor site necessary for HIV to enter and infect cells had opened new possibilities for immunotherapy.
The company is pioneering the use of sheep monoclonal antibodies, which it believes can be used like torpedoes to carry drugs direct to infected and endangered cells in a range of diseases, including cancer.
Sheep monoclonal antibodies have been shown to have a stronger capacity to bind to cells than the rat and mice antibodies most commonly used by scientists.
"The combination of our technology and their scientific expertise and clinical experience will hopefully bring the search for a cure to AIDS another step closer," said KS Biomedix managing director Kim Tan.
970901
RE970901
Copyright © 1997 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .